1. Home
  2. JAGX vs PFSA Comparison

JAGX vs PFSA Comparison

Compare JAGX & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.40

Market Cap

1.0M

Sector

Health Care

ML Signal

HOLD

Logo Profusa Inc.

PFSA

Profusa Inc.

HOLD

Current Price

$0.42

Market Cap

902.5K

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
PFSA
Founded
2013
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0M
902.5K
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
JAGX
PFSA
Price
$0.40
$0.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
686.5K
★ 1.9M
Earning Date
11-16-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 82.42
N/A
EPS
N/A
★ N/A
Revenue
★ $11,511,000.00
$100,000.00
Revenue This Year
$77.78
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.20
$0.40
52 Week High
$41.53
$45,495.00

Technical Indicators

Market Signals
Indicator
JAGX
PFSA
Relative Strength Index (RSI) 39.52 32.35
Support Level $0.29 N/A
Resistance Level $0.46 $1.35
Average True Range (ATR) 0.12 0.08
MACD 0.00 0.13
Stochastic Oscillator 2.13 3.10

Price Performance

Historical Comparison
JAGX
PFSA

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

Share on Social Networks: